0 likes | 0 Views
Graft-versus-host disease (GVHD) is an immune complication from allogeneic stem-cell transplantation, with acute and chronic forms. Risk factors include HLA mismatch, donor age, and conditioning regimens. Steroids remain first-line; emerging treatments target refractory cases. Global GVHD burden is rising alongside transplant volumes.
E N D